Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

GSK shareholders to vote on Novartis deal on Dec. 18
Yahoo/Reuters
Monday, November 24, 2014 - 9:39am
tags:
GSK, Novartis, cancer, consumer health, vaccines, M&A
Merck buys rights to NewLink's experimental Ebola vaccine
Yahoo/Reuters
Monday, November 24, 2014 - 9:37am
tags:
Merck, NewLink, ebola virus, vaccines, M&A
US biotech giant Amgen opens $200m plant in Tuas
Asia One, Singapore
Sunday, November 23, 2014 - 10:21am
tags:
Amgen, Asia
French firm signals 'new era' in malaria fight
The Local, France
Saturday, November 22, 2014 - 11:18am
tags:
Sanofi, antimalarial, malaria, artemisinin
Tetraphase Said to Explore Sale After Takeover Interest
Bloomberg
Saturday, November 22, 2014 - 10:33am
tags:
Tetraphase Pharmaceuticals
Novavax Gains on Fast Track Designation for RSV F Vaccine
Yahoo/Zacks
Saturday, November 22, 2014 - 10:30am
tags:
Novavax, vaccines, RSV
Epizyme Gains on Positive Phase I Data on EPZ-6438
Yahoo/Zacks
Saturday, November 22, 2014 - 10:27am
tags:
Epizyme, EPZ-6438, non-Hodgkin B-cell lymphoma
TrovaGene Cancer Technology Detects KRAS Mutation
Yahoo/Zacks
Saturday, November 22, 2014 - 10:18am
tags:
TrovaGene, KRAS mutation
Pfizer/Merck KGaA Immune Checkpoint Deal Bodes Extremely Well For Compugen
Seeking Alpha
Friday, November 21, 2014 - 3:13pm
tags:
Pfizer, Merck KGaA, CompuGen
Encouraging Results For Two New Drugs That Fight A Common And Dangerous Side Effect
Forbes
Friday, November 21, 2014 - 3:10pm
tags:
RAAS, ZS Pharma, hyperkalemia, ZS-9, Relypsa
MannKind’s Afrezza Remains in Sanofi’s Plans, RBC Says
Barron's
Friday, November 21, 2014 - 3:07pm
tags:
MannKind, inhaled insulin, Afrezza, diabetes, Sanofi
Takeda Pharmaceuticals president quits
Chicago Business
Friday, November 21, 2014 - 1:57pm
tags:
Takeda
FDA approval unlikely as PDUFA date approaches for Avanir
Seeking Alpha
Friday, November 21, 2014 - 11:19am
tags:
FDA, Avanir, migraines, AVP-825
Medtronic realigns diabetes unit
Mass Device
Friday, November 21, 2014 - 11:10am
tags:
Medtronic, diabetes, devices
New data fuels doctors' demands to rewrite U.S. heart guidelines
Reuters
Friday, November 21, 2014 - 11:05am
tags:
LDL cholesterol, heart disease, statins, Merck, Vytorin, AstraZeneca, Pfizer
Novo Nordisk's Victoza receives positive opinion for use in adults with type 2 diabetes
Reuters
Friday, November 21, 2014 - 10:41am
tags:
Novo Nordisk, type 2 diabetes, diabetes, Victoza
IMS Health Study Forecasts Global Spending on Medicines to Increase 30 Percent by 2018, to $1.3 Trillion
IMS Health
Friday, November 21, 2014 - 10:38am
tags:
IMS Health, drug spending
Proposed Rule Calls for Clinical Trial Results to be Reported, Even When Product Isn't Approved
RAPS.org
Friday, November 21, 2014 - 10:36am
tags:
clinical trial data, clinicaltrials.gov
Novartis' Enbrel beater bounds toward psoriasis approval ahead of the crowd
Fierce Biotech
Friday, November 21, 2014 - 10:30am
tags:
Novartis, Enbrel, psoriasis, Cosentyx
Do The IMPROVE-IT Results Offer Promise For Anacetrapib, Another Merck Heart Drug?
Forbes
Friday, November 21, 2014 - 10:26am
tags:
Anacetrapib, Merck, IMPROVE-IT

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.